Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Column Group Iii-A, Lp

10% Owner at Tenaya Therapeutics, Inc. (TNYA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.5M

Reported trades

Filed Stock Type Shares Price Value Since
Feb 24SEC TNYATenaya Therapeutics, Inc. Sell 245,9652,102,218 held (−10%) $0.61 $150K -4.9%
Feb 24SEC TNYATenaya Therapeutics, Inc. Sell 277,7692,374,048 held (−10%) $0.61 $169K -4.9%
Feb 24SEC TNYATenaya Therapeutics, Inc. Sell 143,7091,958,509 held (−7%) $0.60 $86K -3.3%
Feb 24SEC TNYATenaya Therapeutics, Inc. Sell 162,2912,211,757 held (−7%) $0.60 $97K -3.3%
Feb 12SEC TNYATenaya Therapeutics, Inc. Sell 161,4224,253,298 held (−4%) $0.82 $132K -29.3%
Feb 12SEC TNYATenaya Therapeutics, Inc. Sell 182,2954,803,275 held (−4%) $0.82 $149K -29.3%
Feb 12SEC TNYATenaya Therapeutics, Inc. Sell 1,905,1152,348,183 held (−45%) $0.68 $1.3M -14.7%
Feb 12SEC TNYATenaya Therapeutics, Inc. Sell 2,151,4582,651,817 held (−45%) $0.68 $1.5M -14.7%
  • Sell

    10% Owner Column Group Iii-A, Lp sold $1.3M of TNYA at $0.68 — cuts the stake by 45%.

  • Sell

    10% Owner Column Group Iii-A, Lp sold $1.5M of TNYA at $0.68 — cuts the stake by 45%.